Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Alpha Teknova, Inc.

Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports Third Quarter 2024 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports Second Quarter 2024 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Announces Closing of $15.4 Million Private Placement
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Announces $15.4 Million Private Placement
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports First Quarter 2024 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Report First Quarter 2024 Financial Results on May 13, 2024
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports Third Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Announces New Board Member, Martha J. Demski
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports Second Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova to Participate in Upcoming Investor Conference
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Teknova Reports First Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Tickers TKNO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.